Literature DB >> 28770379

Checkpoint Inhibitor-Associated Hypophysitis.

Lee-Shing Chang1, Maria A Yialamas2.   

Abstract

Entities:  

Keywords:  checkpoint inhibitors; hypophysitis; immunotherapy; ipilimumab; nivolumab

Mesh：

Substances：

Year:  2017        PMID： 28770379      PMCID： PMC5756152          DOI： 10.1007/s11606-017-4135-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  2 in total

Review 1.  Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights.

Authors:  Alexander Faje
Journal:  Pituitary       Date:  2016-02       Impact factor: 4.107

Review 2.  Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.

Authors:  M N Joshi; B C Whitelaw; M T P Palomar; Y Wu; P V Carroll
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-13       Impact factor: 3.478
  2 in total
  2 in total

Review 1.  Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review.

Authors:  Maria Stelmachowska-Banaś; Izabella Czajka-Oraniec
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335

Review 2.  Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancer.

Authors:  Hannah Elizabeth Green; Jorge Nieva
Journal:  J Investig Med       Date:  2021-06-14       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.